These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 703709)
1. [Hemopathies caused by drugs in children: aplastic anemia, agranulocytosis, megaloblastic anemia]. Masera G; Baronciani D; Conti A; Jankovic M; Uderzo C Minerva Pediatr; 1978 Sep; 30(18):1463-72. PubMed ID: 703709 [No Abstract] [Full Text] [Related]
2. [Iatrogenic hemopathies. Current aspects of drug effects on the formal elements of the blood]. Angela GC; Di Siena F Minerva Med; 1970 Dec; 61(98):5659-76. PubMed ID: 4100810 [No Abstract] [Full Text] [Related]
3. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study. Arch Intern Med; 1989 May; 149(5):1036-40. PubMed ID: 2785785 [TBL] [Abstract][Full Text] [Related]
4. [Drug-induced megaloblastic anemia]. Heilmann E Med Klin; 1979 Aug; 74(34):1207-16. PubMed ID: 388170 [No Abstract] [Full Text] [Related]
5. Possible role of methotrexate in trimethoprim-sulfamethoxazole-induced acute megaloblastic anemia. Dan M; Shapira I Isr J Med Sci; 1984 Mar; 20(3):262-3. PubMed ID: 6724876 [No Abstract] [Full Text] [Related]
6. [Drugs and blood]. Keiser G Schweiz Rundsch Med Prax; 1985 Jan; 74(3):40-5. PubMed ID: 2857497 [No Abstract] [Full Text] [Related]
7. [Complete bone marrow suppression and megaloblastic anemia as a result of long-term treatment with cotrimoxazole]. Hellmann A; Nering I Pol Tyg Lek; 1977 Nov; 32(46):1801-2. PubMed ID: 593952 [No Abstract] [Full Text] [Related]
8. [Pancytopenic megaloblastic anaemia following administration of pyrimethamine, trimethoprim and sulphamethoxazole (author's transl)]. Malfatti S; Piccini A Haematologica; 1976 Sep; 61(3):349-57. PubMed ID: 828128 [No Abstract] [Full Text] [Related]
12. Acute megaloblastic anemia induced by high-dose trimethoprim-sulfamethoxazole. Kobrinsky NL; Ramsay NK Ann Intern Med; 1981 Jun; 94(6):780-1. PubMed ID: 6972183 [No Abstract] [Full Text] [Related]
13. Megaloblastic anaemia produced by drugs. Stebbins R; Bertino JR Clin Haematol; 1976 Oct; 5(3):619-30. PubMed ID: 788981 [No Abstract] [Full Text] [Related]
14. [Bone marrow megaloblastosis associated with the use of pyrimethamine, triamterene and trimethoprim-sulfamethoxazole]. Anguita T Rev Med Chil; 1982 Jun; 110(6):570-9. PubMed ID: 6984535 [No Abstract] [Full Text] [Related]
15. Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole. Frisch JM J Infect Dis; 1973 Nov; 128():Suppl:607-12 p. PubMed ID: 4271305 [No Abstract] [Full Text] [Related]
16. Megaloblastosis and low-dose trimethoprim-sulfamethoxazole. Magee F; O'Sullivan H; McCann SR Ann Intern Med; 1981 Nov; 95(5):657. PubMed ID: 7294566 [No Abstract] [Full Text] [Related]
17. Megaloblastic anaemia associated with combined pyrimethamine and co-trimoxazole administration. Ansdell VE; Wright SG; Hutchinson DB Lancet; 1976 Dec; 2(7997):1257. PubMed ID: 63088 [No Abstract] [Full Text] [Related]
18. [Secondary blood dyscrasias due to drugs and chemical agents. Study in patients hospitalized in the Hematology Service of the Hospital das ClĂnicas of the F.M.U.S.P. from 1955 to 1975]. de Cillo DM; Santana MO; Mori NS; Jamra M Rev Hosp Clin Fac Med Sao Paulo; 1978 Feb; 33(1):33-8. PubMed ID: 307268 [No Abstract] [Full Text] [Related]